| Sanofi Signs US$2.54 B Collaboration Deal with Skyhawk Therapeutics for RNA-splicing Modulators |
Abstract
pdf
html
|
|
Ashish Tripathi |
|
| Generian and Mitobridge Form Alliance to Develop Novel Small Molecules for Undruggable Targets |
Abstract
pdf
html
|
|
Swati Sharan |
|
| Merck & Co. Collaborates with Orion to Develop and Commercialise ODM-208 for US$290 M |
Abstract
pdf
html
|
|
Ashish Tripathi |
|
| Merck & Co. Pays US$35 M Upfront for Kelun-Biotech’s ADC Oncology Drug |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Takeda Licenses F-star’s Immuno-oncology Bispecific Antibody Technology |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Vertex Signs Gene Editing Partnership with Verve for US$466 M |
Abstract
pdf
html
|
|
Swati Sharan |
|
| Galapagos Acquires CellPoint and AboundBio for Next-Generation Cell Therapies |
Abstract
pdf
html
|
|
Swati Sharan |
|
| AstraZeneca Acquires TeneoTwo in US$1.27 B Deal |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Vertex Buys ViaCyte for Diabetes Stem Cell Treatment |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Ipsen Acquires Epizyme to Broaden its Oncology Portfolio |
Abstract
pdf
html
|
|
Ayush Saxena |
|
